Type 2 Diabetes

Posted on Posted in studies

The Lonicera approach on Type 2 Diabetes (T2D) is based on the robust understanding of the benefits of probiotics in diabetes at the cellular level, in both animal studies and clinical trials, based on their excellent tolerability record.

The gut microbiota shows substantial differences between adults with T2D and non-diabetic individuals. Lonicera is currently proposing the use of probiotics to target 3 different main T2D problem areas: high glucose levels, inflammation, and abnormal blood lipid levels.

STAY TUNED for More!